The graph below gives you a visual look at CRSP’s recent movement. We will get into why these numbers matter below, and get in more detail through out the article. For now enjoy the graph we have created for you.
- Price Open: The price as of market open.
- Change: The price change since the previous trading day’s close.
- High: The current day’s high price.
- Low: The current day’s low price.
In this article, we will be analyzing Crispr Therapeutics AG. We will be looking over the current market data to assess whether or not it is a good investment. To get started, the stock opened this morning at $98.35 and has moved $1.93 from yesterday’s closing price of $96.77. The high for today is $102.67 and the low is $96.6. A great indicator of where a stock is trending is by looking at its 52-week high/low. This is a technical indicator used by some traders and investors who view these figures as an important factor in the analysis of a stock’s current value and as a predictor of its future price movement.
The 52-week high for Crispr Therapeutics AG is $220.2 and the low is $84.38. We will be moving onto the number of outstanding shares. One is that you can use shares outstanding to calculate the market capitalization, the total value, of a corporation. Multiply the price of a single stock by the number of shares outstanding to find a business’s market capitalization. The number of outstanding shares for Crispr Therapeutics AG is 76201000. Now that you know more about Crispr Therapeutics AG stands, let’s learn more about the future of the company.
Forecast & Beta
As an investor, you can get an idea of where the stock is trending by the forecast and beta. Beta is calculated using regression analysis. A beta of 1 indicates that the security’s price tends to move with the market. A beta greater than 1 indicates that the security’s price tends to be more volatile than the market. A beta of less than 1 means it tends to be less volatile than the market. Crispr Therapeutics AG has a beta of 0.5. Knowing all of this, we project that Crispr Therapeutics AG will have a price of $128.31 in 12-months compared to its current price of $98.7
We can also take a look at the company’s market cap. Market cap is important because it allows investors to understand the relative size of one company versus another. Market cap measures what a company is worth on the open market, as well as the market’s perception of its prospects because it reflects what investors are willing to pay for its stock. Crispr Therapeutics AG has a market cap of $7521055246.
Stock analysis is a method for investors and traders to make buying and selling decisions. Investors and traders try to gain an edge in the markets by making informed decisions through analyzing the past and current data. The ultimate goal is to arrive at a number that can be compared to the present price of a security to determine whether it is undervalued or overvalued. View the chart below to get a better understanding of how the stock has been moving.
The chart above displays the price history to help you determine whether the stock is appreciating or depreciating in value. If you do not use stock charts you’re essentially investing with a blindfold. You won’t be able to see what’s really happening with the stock.